Cellular protein breakdown and systemic inflammation are unaffected by pulmonary rehabilitation in COPD

被引:46
作者
Bolton, Charlotte E. [1 ]
Broekhuizen, Roelinka
Lonescu, Alina A.
Nixon, Lisette S.
Wouters, Emiel F. M.
Shale, Dennis J.
Schols, Annemie M. W. J.
机构
[1] Cardiff Univ, Dept Resp Med, Sch Med, Acad Ctr,Llandough Hosp, Vale Of Glamorgan CF64 2XX, Wales
[2] Univ Hosp Maastricht, Dept Resp Med, Maastricht, Netherlands
关键词
D O I
10.1136/thx.2006.060368
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Pulmonary rehabilitation can improve the functional capacity, but has a variable effect on the low fat- free mass ( FFM) in patients with chronic obstructive pulmonary disease. Hypothesis: Pulmonary rehabilitation would not affect catabolic drives such as systemic inflammation and also protein breakdown. Methods: Patients ( n = 40) were studied at the start of an 8- week in- patient pulmonary rehabilitation programme, at the end of the programme and 4 weeks later. FFM and functional capacity ( quadriceps strength, handgrip strength and peak workload) were assessed. Pseudouridine ( PSU) urinary excretion ( cellular protein breakdown) and inflammatory status were determined. Healthy participants had a single baseline assessment ( n = 18). Results: PSU, (IL)- 6 and soluble tumour necrosis factor ( sTNF)alpha R75 were increased in patients compared with healthy participants, whereas FFM and functional capacity were reduced ( all p < 0.01). PSU was inversely related to both FFM and skeletal muscle function. FFM and functional parameters increased with rehabilitation, but PSU and inflammatory status were unaffected. The gain in FFM was lost 4 weeks after the completion of rehabilitation ( p < 0.01). Conclusion: The anabolic effect of pulmonary rehabilitation improved FFM, but it did not reverse the increased protein breakdown or systemic inflammation. Thus, on cessation of pulmonary rehabilitation the FFM gains were lost owing to a loss of anabolic drive.
引用
收藏
页码:109 / 114
页数:6
相关论文
共 41 条
[1]   Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease [J].
Agustí, AGN ;
Sauleda, J ;
Miralles, C ;
Gomez, C ;
Togores, B ;
Sala, E ;
Batle, S ;
Busquets, X .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (04) :485-+
[2]   Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure [J].
Anker, SD ;
Ponikowski, PP ;
Clark, AL ;
Leyva, F ;
Rauchhaus, M ;
Kemp, M ;
Teixeira, MM ;
Hellewell, PG ;
Hooper, J ;
Poole-Wilson, PA ;
Coats, AJS .
EUROPEAN HEART JOURNAL, 1999, 20 (09) :683-693
[3]   Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease [J].
Baarends, EM ;
Schols, AMWJ ;
Mostert, R ;
Wouters, EFM .
EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (12) :2807-2813
[4]   Out-patient rehabilitation improves activities of daily living, quality of life and exercise tolerance in chronic obstructive pulmonary disease [J].
Bendstrup, KE ;
Jensen, JI ;
Holm, S ;
Bengtsson, B .
EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (12) :2801-2806
[5]   Aerobic and strength training in patients with chronic obstructive pulmonary disease [J].
Bernard, S ;
Whittom, F ;
LeBlanc, P ;
Jobin, J ;
Belleau, R ;
Bérubé, C ;
Carrier, G ;
Maltais, F .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) :896-901
[6]   The effect of human growth hormone therapy on L-(methyl-H-2(3))-leucine turnover and urinary pseudouridine concentration in patients with Ullrich-Turner syndrome [J].
Bohles, H ;
Brendel, L ;
Forster, H ;
Trager, K ;
Vogt, J ;
Georgieff, M .
EUROPEAN JOURNAL OF PEDIATRICS, 1996, 155 (04) :275-280
[7]   Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease [J].
Bolton, CE ;
Ionescu, AA ;
Shiels, KM ;
Pettit, RJ ;
Edwards, PH ;
Stone, MD ;
Nixon, LS ;
Evans, WD ;
Griffiths, TL ;
Shale, DJ .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (12) :1286-1293
[8]   Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper [J].
Celli, BR ;
MacNee, W ;
Agusti, A ;
Anzueto, A ;
Berg, B ;
Buist, AS ;
Calverley, PMA ;
Chavannes, N ;
Dillard, T ;
Fahy, B ;
Fein, A ;
Heffner, J ;
Lareau, S ;
Meek, P ;
Martinez, F ;
McNicholas, W ;
Muris, J ;
Austegard, E ;
Pauwels, R ;
Rennard, S ;
Rossi, A ;
Siafakas, N ;
Tiep, B ;
Vestbo, J ;
Wouters, E ;
ZuWallack, R .
EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (06) :932-946
[9]   Efficacy of nutritional supplementation therapy in depleted patients with chronic obstructive pulmonary disease [J].
Creutzberg, EC ;
Wouters, EFM ;
Mostert, R ;
Weling-Scheepers, CAPM ;
Schols, AMWJ .
NUTRITION, 2003, 19 (02) :120-127
[10]   Catabolic/anabolic balance and muscle wasting in patients with COPD [J].
Debigaré, R ;
Marquis, K ;
Côté, CH ;
Tremblay, RR ;
Michaud, A ;
LeBlanc, P ;
Maltais, F .
CHEST, 2003, 124 (01) :83-89